News
Image of Shanghai street

China clears GSK's Nucala for COPD

GSK has unlocked a big new market for Nucala for COPD - China - which accounts for around a quarter of the global patient population.

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D

Partner Content

Partner Content
LEAP HR: Life Sciences Europe
Partner Content

LEAP HR: Life Sciences Europe

Europe’s Only Industry-Specific Meeting Advancing HR Excellence in Life Sciences